The venture, announced byIntermountain in January, said it plans to have its first productsready by as early as next year. (Photo: Getty)

A drugmaking venture backed by major U.S.hospitals has picked a chief executive officer, hastening thearrival of another threat to generic pharmaceutical manufacturers.

Martin VanTrieste, 58 and a former top executive atbiotechnology giant Amgen Inc., will run the organization, anot-for-profit called Civica Rx. Dan Liljenquist, 44 and anIntermountain Healthcare executive, will be chairman. Healthsystems with a total of about 500 hospitals — includingIntermountain, HCA Healthcare Inc., Mayo Clinic and Catholic HealthInitiatives — will help govern the venture, alongside severalphilanthropies.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.